Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood
Authors:
- Wladimir MauhinWMWladimir Mauhin
- Florence HabarouFHFlorence Habarou
- Stéphanie GobinSGStéphanie Gobin
- Aude ServaisASAude Servais
- Anaïs BrassierABAnaïs Brassier
- Coraline GriselCGCoraline Grisel
- Célina RodaCRCélina Roda
- Graziella PintoGPGraziella Pinto
- Despina MoshousDMDespina Moshous
- Fahd GhalimFGFahd Ghalim
- Pauline KrugPKPauline Krug
- Nelly DeltourNDNelly Deltour
Open Access
- 5 January 2017
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 12 (1) , 3
Abstract
Lysinuric protein intolerance (LPI) is a rare metabolic disease resulting from recessive-inherited mutations in the SLC7A7 gene encoding the cationic amino-acids transporter subunit y+LAT1. The disease is characterised by protein-rich food intolerance with secondary urea cycle disorder, but symptoms are heterogeneous ranging from infiltrative lung disease, kidney failure to auto-immune complications. This retrospective study of all cases treated at Necker Hospital (Paris, France) since 1977 describes LPI in both children and adults in order to improve therapeutic management. Sixteen patients diagnosed with LPI (12 males, 4 females, from 9 families) were followed for a mean of 11.4 years (min-max: 0.4-37.0 years). Presenting signs were failure to thrive (n = 9), gastrointestinal disorders (n = 2), cytopenia (n = 6), hyperammonemia (n = 10) with acute encephalopathy (n = 4) or developmental disability (n = 3), and proteinuria (n = 1). During follow-up, 5 patients presented with acute hyperammonemia, and 8 presented with developmental disability. Kidney disease was observed in all patients: tubulopathy (11/11), proteinuria (4/16) and kidney failure (7/16), which was more common in older patients (mean age of onset 17.7 years, standard deviation 5.33 years), with heterogeneous patterns including a lupus nephritis. We noticed a case of myocardial infarction in a 34-year-old adult. Failure to thrive and signs of haemophagocytic-lymphohistiocytosis were almost constant. Recurrent acute pancreatitis occurred in 2 patients. Ten patients developed an early lung disease. Six died at the mean age of 4 years from pulmonary alveolar proteinosis. This pulmonary involvement was significantly associated with death. Age-adjusted plasma lysine concentrations at diagnosis showed a trend toward increased values in patients with a severe disease course and premature death (Wilcoxon p = 0.08; logrank, p = 0.17). Age at diagnosis was a borderline predictor of overall survival (logrank, p = 0.16). As expected, early pulmonary involvement with alveolar proteinosis is frequent and severe, being associated with an increased risk of death. Kidney disease frequently occurs in older patients. Cardiovascular and pancreatic involvement has expanded the scope of complications. A borderline association between increased levels of plasma lysine and poorer outome is suggested. Greater efforts at prevention are warranted to optimise the long-term management in these patients.Keywords
This publication has 44 references indexed in Scilit:
- Familial Hemophagocytic Lymphohistiocytosis May Present during Adulthood: Clinical and Genetic Features of a Small SeriesPLOS ONE, 2012
- Lysine triggers apoptosis through a NADPH oxidase‐dependent mechanism in human renal tubular cellsJournal of Inherited Metabolic Disease, 2012
- Exploring the transcriptomic variation caused by the Finnish founder mutation of lysinuric protein intolerance (LPI)Molecular Genetics and Metabolism, 2012
- Lysinuric protein intolerance: Reviewing concepts on a multisystem diseaseAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophagesOrphanet Journal of Rare Diseases, 2010
- Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRα gene in the X chromosome pseudoautosomal region 1Journal of Experimental Medicine, 2008
- Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeatEuropean Journal of Human Genetics, 2008
- Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intoleranceThe Journal of Pediatrics, 2004
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997
- Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical courseThe Journal of Pediatrics, 1995